ReviewPharmaceuticals (Basel, Switzerland)2024

Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs.

Yizhi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.